Transcription of COVID-19 Vaccine Active Surveillance and Reporting of ...
{{id}} {{{paragraph}}}
Example: stock market
COVID-19 Vaccine Active Surveillance and Reporting of ...
COVID-19 Vaccine Active Surveillance and Reporting of Adverse Events Following Immunization (AEFI). Revised: December 15, 2021. This policy is evergreen and will be updated as new information becomes available. Table of Contents I. 2. II. Legislative Authority .. 2. III. Reporting to Alberta Health Services (AHS) .. 3. When to report to Alberta Health Services .. 3. What to report to Alberta Health Services .. 3. Data elements .. 3. IV. AEFI versus AESI (Adverse Events of Special Interest) .. 4. V. Adverse Events of Special Interest Following COVID-19 5. Acute aseptic arthritis .. 6. Acute cardiovascular injury .. 7. Myocarditis .. 8. Acute kidney 9. Acute liver injury .. 9. Acute respiratory distress syndrome.
Dec 15, 2021 · I. Introduction The monitoring of adverse events following immunization (AEFI) involving vaccines and biologicals ... ST elevation, arrhythmia) or echocardiography or cardia MRI OR 4. Has at least one cardiac troponin (cTn) or creatinine kinase-MB concentration that is above the 99th percentile upper reference limit regardless of symptoms AND 5 ...
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: